Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics

Peptide antigens bound to molecules encoded by the major histocompatibility complex (MHC) and presented on the cell surface form the targets of T lymphocytes. This critical arm of the adaptive immune system facilitates the eradication of pathogen-infected and cancerous cells, as well as the production of antibodies. Methods to identify these peptide antigens are critical to the development of new vaccines, for which the goal is the generation of effective adaptive immune responses and long-lasting immune memory. Here, we describe a robust protocol for the identification of MHC-bound peptides from cell lines and tissues, using nano-ultra-performance liquid chromatography coupled to high-resolution mass spectrometry (nUPLC–MS/MS) and recent improvements in methods for isolation and characterization of these peptides. The protocol starts with the immunoaffinity capture of naturally processed MHC-peptide complexes. The peptides dissociate from the class I human leukocyte antigens (HLAs) upon acid denaturation. This peptide cargo is then extracted and separated into fractions by HPLC, and the peptides in these fractions are identified using nUPLC–MS/MS. With this protocol, several thousand peptides can be identified from a wide variety of cell types, including cancerous and infected cells and those from tissues, with a turnaround time of 2–3 d.Peptide antigens are bound to molecules encoded by the major histocompatibility complex (MHC) and presented on the cell surface as targets for T lymphocytes. This protocol uses nUPLC–MS/MS to identify MHC-bound peptides from cell lines and tissues.

[1]  N. Croft,et al.  A comprehensive analysis of peptides presented by HLA-A1. , 2015, Tissue antigens.

[2]  Jüergen Cox,et al.  The MaxQuant computational platform for mass spectrometry-based shotgun proteomics , 2016, Nature Protocols.

[3]  Mark M. Davis,et al.  Enumeration and Characterization of Memory Cells in the TH Compartment , 1996, Immunological reviews.

[4]  Nicholas A Williamson,et al.  Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA A*02:01 ligands. , 2012, Molecular immunology.

[5]  Christian Brander,et al.  Direct Interrogation of Viral Peptides Presented by the Class I HLA of HIV-Infected T Cells , 2014, Journal of Virology.

[6]  S. H. van der Burg,et al.  The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy , 2017, Front. Immunol..

[7]  T. Merigan,et al.  Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). , 1999, Journal of immunology.

[8]  L. Lampson,et al.  Two populations of Ia-like molecules on a human B cell line. , 1980, Journal of immunology.

[9]  Ilan Beer,et al.  Large-scale analysis of HLA peptides presented by HLA-Cw4 , 2003, Immunogenetics.

[10]  R. Henderson,et al.  Mass spectrometric analysis of peptides associated with the human class I MHC molecules HLA-A2.1 and HLA-B7 and identification of structural features that determine binding. , 1993, Chemical Immunology.

[11]  G. Nepom.  MHC Class II Tetramers , 2012, The Journal of Immunology.

[12]  N. Croft,et al.  Human Leukocyte Antigen (HLA) B27 Allotype-Specific Binding and Candidate Arthritogenic Peptides Revealed through Heuristic Clustering of Data-independent Acquisition Mass Spectrometry (DIA-MS) Data* , 2016, Molecular & Cellular Proteomics.

[13]  M. Nielsen,et al.  The Length Distribution of Class I–Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele–Specific Binding Preference , 2016, The Journal of Immunology.

[14]  M. Lotze,et al.  Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[15]  David Gfeller,et al.  Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity , 2017, bioRxiv.

[16]  J. Shabanowitz,et al.  An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins , 1996, The Journal of experimental medicine.

[17]  G. Nepom,et al.  Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  L. Jensen,et al.  Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation* , 2015, Molecular & Cellular Proteomics.

[19]  Hans-Georg Rammensee,et al.  Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells , 1990, Nature.

[20]  L. Mechetina,et al.  Peptide–MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development , 2015, Expert review of vaccines.

[21]  Shabaz Mohammed,et al.  Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity* , 2016, Molecular & Cellular Proteomics.

[22]  Morten Nielsen,et al.  Simultaneous alignment and clustering of peptide data using a Gibbs sampling approach , 2013, Bioinform..

[23]  Ilan Beer,et al.  Soluble plasma HLA peptidome as a potential source for cancer biomarkers , 2010, Proceedings of the National Academy of Sciences.

[24]  Forest M. White,et al.  Phosphorylated Peptides Are Naturally Processed and Presented by Major Histocompatibility Complex Class I Molecules in Vivo , 2000, The Journal of experimental medicine.

[25]  H. Rammensee,et al.  SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.

[26]  Petra Bacher,et al.  Flow‐cytometric analysis of rare antigen‐specific T cells , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[27]  M. Nielsen,et al.  Defining the HLA class I‐associated viral antigen repertoire from HIV‐1‐infected human cells , 2015, European journal of immunology.

[28]  P. Srivastava,et al.  Neoepitopes as cancer immunotherapy targets: key challenges and opportunities. , 2017, Immunotherapy.

[29]  P. Parham,et al.  Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. , 1981, Human immunology.

[30]  P. Cresswell,et al.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides , 1992, Nature.

[31]  S. Nathenson,et al.  Methods to study peptides associated with MHC class I molecules. , 1994, Current opinion in immunology.

[32]  P. Edwards,et al.  A human‐human hybridoma system based on a fast‐growing mutant of the ARH‐77 plasma cell leukemia‐derived line , 1982, European journal of immunology.

[33]  Nuno Bandeira,et al.  Expanding Proteome Coverage with Orthogonal-specificity α-Lytic Proteases* , 2014, Molecular & Cellular Proteomics.

[34]  Forest M. White,et al.  Immunodominance Among EBV-Derived Epitopes Restricted by HLA-B27 Does Not Correlate with Epitope Abundance in EBV-Transformed B-Lymphoblastoid Cell Lines1 , 2000, The Journal of Immunology.

[35]  P. Borrow,et al.  Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows , 2018, Front. Immunol..

[36]  A. Brooks,et al.  Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexes , 2003, European journal of immunology.

[37]  Albert J R Heck,et al.  Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD) , 2014, Proceedings of the National Academy of Sciences.

[38]  Mark Cobbold,et al.  Complementary IMAC enrichment methods for HLA-associated phosphopeptide identification by mass spectrometry , 2015, Nature Protocols.

[39]  Darren R. Flower,et al.  Towards the knowledge-based design of universal influenza epitope ensemble vaccines , 2016, Bioinform..

[40]  B. Vincent,et al.  The Use of Peptide-Major-Histocompatibility-Complex Multimers in Type 1 Diabetes Mellitus , 2012, Journal of diabetes science and technology.

[41]  James McCluskey,et al.  More than one reason to rethink the use of peptides in vaccine design , 2007, Nature Reviews Drug Discovery.

[42]  C. Parra-López,et al.  Major Histocompatibility Complex and T Cell Interactions of a Universal T Cell Epitope from Plasmodium falciparum Circumsporozoite Protein* , 2006, Journal of Biological Chemistry.

[43]  Morten Nielsen,et al.  Gapped sequence alignment using artificial neural networks: application to the MHC class I system , 2016, Bioinform..

[44]  A. McMichael,et al.  TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide , 1998, Current Biology.

[45]  M. Mann,et al.  Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry , 2016, Nature Communications.

[46]  D. Margulies,et al.  Abacavir induces loading of novel self-peptides into HLA-B*57: 01 an autoimmune model for HLA-associated drug hypersensitivity , 2012, AIDS.

[47]  Elisa Pappalardo,et al.  Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells , 2015, Journal of Virology.

[48]  Alessandro Sette,et al.  Discovering naturally processed antigenic determinants that confer protective T cell immunity. , 2013, The Journal of clinical investigation.

[49]  Morten Nielsen,et al.  Seq2Logo: a method for construction and visualization of amino acid binding motifs and sequence profiles including sequence weighting, pseudo counts and two-sided representation of amino acid enrichment and depletion , 2012, Nucleic Acids Res..

[50]  T. D. Schneider,et al.  Sequence logos: a new way to display consensus sequences. , 1990, Nucleic acids research.

[51]  Denis Hochstrasser,et al.  A Totally Synthetic Polyoxime Malaria Vaccine Containing Plasmodium falciparum B Cell and Universal T Cell Epitopes Elicits Immune Responses in Volunteers of Diverse HLA Types1 , 2001, The Journal of Immunology.

[52]  B. Johansen,et al.  Two HLA-DQ-specific human-human hybridoma antibodies (TrG6;TrC5) define epitopes also expressed by a transcomplementing hybrid DQ molecule (DQw7 alpha/DQw4 beta). , 1989, Human immunology.

[53]  D. Hunt,et al.  Direct analysis of tumor-associated peptide antigens. , 1994, Current opinion in immunology.

[54]  R. Toes,et al.  A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis , 2013, The Journal of experimental medicine.

[55]  R. Henderson,et al.  Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. , 1994, Science.

[56]  John Sidney,et al.  Immunomic Analysis of the Repertoire of T-Cell Specificities for Influenza A Virus in Humans , 2008, Journal of Virology.

[57]  H. Rammensee,et al.  Chemistry of peptides associated with MHC class I and class II molecules. , 1995, Current opinion in immunology.

[58]  A. Heck,et al.  Six alternative proteases for mass spectrometry–based proteomics beyond trypsin , 2016, Nature Protocols.

[59]  Ash A. Alizadeh,et al.  Antigen Presentation Profiling Reveals Recognition of Lymphoma Immunoglobulin Neoantigens , 2017, Nature.

[60]  P. Kloetzel,et al.  A large fraction of HLA class I ligands are proteasome-generated spliced peptides , 2016, Science.

[61]  J. A. Payne,et al.  Differential transport requirements of HLA and H-2 class I glycoproteins , 2004, Immunogenetics.

[62]  D. N. Perkins,et al.  Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.

[63]  Towards identification of immune and genetic correlates of severe influenza disease in Indigenous Australians , 2015, Immunology and cell biology.

[64]  G. Air,et al.  HLA class I molecules consistently present internal influenza epitopes , 2009, Proceedings of the National Academy of Sciences.

[65]  J. Yates,et al.  An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database , 1994, Journal of the American Society for Mass Spectrometry.

[66]  J. Altman,et al.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.

[67]  Ilan Beer,et al.  Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor‐specific antigens , 2002, European journal of immunology.

[68]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[69]  A. Purcell,et al.  Revisiting the Arthritogenic Peptide Theory: Quantitative Not Qualitative Changes in the Peptide Repertoire of HLA–B27 Allotypes , 2015, Arthritis & rheumatology.

[70]  Hans-Georg Rammensee,et al.  Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules , 2004, Immunogenetics.

[71]  F. Bach,et al.  Detection of a novel human class II HLA antigen , 1983, Nature.

[72]  H. Rammensee,et al.  Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast , 1991, The Journal of experimental medicine.

[73]  Sean L Seymour,et al.  The Paragon Algorithm, a Next Generation Search Engine That Uses Sequence Temperature Values and Feature Probabilities to Identify Peptides from Tandem Mass Spectra*S , 2007, Molecular & Cellular Proteomics.

[74]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[75]  E. Padlan,et al.  Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex , 1992, The Journal of experimental medicine.

[76]  J. Shabanowitz,et al.  Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for presentation of transformed self , 2008, Nature Immunology.

[77]  Roman A. Zubarev,et al.  The SysteMHC Atlas project , 2017, Nucleic Acids Res..

[78]  J. Strominger,et al.  Immunochemically purified DR antigens in liposomes stimulate xenogeneic cytolytic T cells in secondary in vitro cultures. , 1986, Cellular immunology.

[79]  N. Croft,et al.  Characterization of the Antigen Processing Machinery and Endogenous Peptide Presentation of a Bat MHC Class I Molecule , 2016, The Journal of Immunology.

[80]  A. Agulnik,et al.  The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. , 1997, Immunity.

[81]  E. Unanue,et al.  Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[82]  A. McMichael,et al.  Recognition of HLA-B27 and related antigen by a monoclonal antibody. , 1982, Human immunology.

[83]  F. Bach,et al.  Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[84]  Anthony W Purcell,et al.  In Immunopeptidomics We Need a Sniper Instead of a Shotgun , 2018, Proteomics.

[85]  Sri H. Ramarathinam,et al.  A comprehensive analysis of constitutive naturally processed and presented HLA-C*04:01 (Cw4)-specific peptides. , 2014, Tissue antigens.

[86]  T. Schumacher,et al.  Generation of peptide–MHC class I complexes through UV-mediated ligand exchange , 2006, Nature Protocols.

[87]  Alessandro Sette,et al.  An open-source computational and data resource to analyze digital maps of immunopeptidomes , 2015, eLife.

[88]  Sri H. Ramarathinam,et al.  A Systems Approach to Understand Antigen Presentation and the Immune Response. , 2016, Methods in molecular biology.

[89]  M. Lotze,et al.  Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. , 1993, Journal of immunology.

[90]  S. Nathenson,et al.  Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule , 1990, Nature.

[91]  J. McCluskey,et al.  Immune self-reactivity triggered by drug-modified HLA-peptide repertoire , 2012, Nature.

[92]  Bin Ma,et al.  PEAKS DB: De Novo Sequencing Assisted Database Search for Sensitive and Accurate Peptide Identification* , 2011, Molecular & Cellular Proteomics.

[93]  D E Geraghty,et al.  Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[94]  M. Diamond,et al.  Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late , 2016, The Journal of Immunology.

[95]  D. Ge,et al.  HLA-C cell surface expression and control of HIV / AIDS correlate with a variant upstream of HLA-C , 2009 .

[96]  B. Johansen,et al.  Two HLA-DQ-specific human-human hybridoma antibodies (TrG6, TrC5) define epitopes also expressed by a transcomplementing hybrid DQ molecule (DQw7α/DQw4β) , 1989 .

[97]  P. Marrack,et al.  Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse , 2011, Proceedings of the National Academy of Sciences.

[98]  Anthony W. Purcell,et al.  The Cellular Redox Environment Alters Antigen Presentation* , 2014, The Journal of Biological Chemistry.

[99]  R. Henderson,et al.  Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.

[100]  Jennifer G. Abelin,et al.  Mass Spectrometry Profiling of HLA‐Associated Peptidomes in Mono‐allelic Cells Enables More Accurate Epitope Prediction , 2017, Immunity.

[101]  Robertson Craig,et al.  TANDEM: matching proteins with tandem mass spectra. , 2004, Bioinformatics.

[102]  D. Hafler,et al.  Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. , 1999, Journal of immunology.

[103]  M. Lotze,et al.  Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes , 1995, The Journal of experimental medicine.

[104]  O. Lund,et al.  novel sequence representations Reliable prediction of T-cell epitopes using neural networks with , 2003 .

[105]  H. Rammensee,et al.  A self peptide naturally presented by both H-2Kb and H-2Kbm1 molecules demonstrates MHC restriction of self tolerance at the molecular level. , 1992, International immunology.